Remove Hurdles to Cancer Care


COVID-19 has shone a spotlight on the significant barriers to affordable health care that cancer patients have long faced. While relief packages and proposals to date have worked to address affordability of COVID-specific testing and treatment, policymakers must also tackle hurdles that cancer patients face like removing the red tape of prior authorization and step therapy, reducing out-of-pocket costs, and ensuring cost-sharing assistance directly benefits patients. There has been a great deal of research and investment in effective therapies that allow people fighting cancer to survive and live longer. Cancer patients need Congress to act quickly to remove hurdles to quality care.

56% of cancer patients and survivors are worried about being able to afford their treatment

Latest Updates

May 9, 2024

Nearly half (49%) of cancer patients and survivors report being burdened by medical debt alongside some (13%) who report expecting to incur medical debt as part of their treatment plan, according to a new Survivor Views survey by the American Cancer Society Cancer Action Network (ACS CAN).

April 29, 2024

Today, the Food and Drug Administration (FDA) finalized a new rule regulating laboratory developed tests (LDTs) that will harmonize oversight for diagnostic tests regardless of whether tests are performed in individual laboratories or sold as prepackaged kits.

April 2, 2024

Researchers from Fred Hutchinson Cancer Center , the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are considered, at least one in five people with cancer, or 21.9%, participate in some form of clinical research.

March 19, 2024
Rhode Island

Rhode Island lawmakers have taken the first step towards improving prescription drug affordability for cancer patients and others with chronic diseases.

Remove Hurdles to Cancer Care Resources

Patient Assistance Programs

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) along with partners appreciate the opportunity to comment on the Patient Navigation provisions of CY2024 Medicare Physician Fee Schedule.